课题基金 / 基金详情

Monitoring of leucocyte cytokine-chemokines to improve morbidity and rejection rates in lung transplant patients

Monitoring of leucocyte cytokine-chemokines to improve morbidity and rejection rates in lung transplant patients
监测白细胞细胞因子趋化因子以改善肺移植患者的发病率和排斥率
批准号:
nhmrc : 508121
负责人:
A/Pr Daniel Chambers
金额:
$24.94万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2008
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2008-01-01 至 2011-12-31

项目摘要

项目成果

A/Pr Daniel Chambers的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lung transplantation has become established therapy for many serious lung diseases. The early success rate is now very good, but at five years after transplant the survival rate is only around 60%. This problem is largely due to chronic graft failue as a result of chronic rejection or bronchiolitis obliterans syndrome. This project will specifically investigate the causes of BOS and thereby provide new information on how we may best treat this problem. An improvement in this area is critical.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ambulatory oxygen for interstitial lung disease
  • 批准号:
    nhmrc : 1139953
  • 项目类别:
    Project Grants
  • 资助金额:
    $101.67万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Daniel Chambers
  • 依托单位:
Modulation of lung regeneration and remodeling by the innate immune system.
  • 批准号:
    nhmrc : 1147256
  • 项目类别:
    Project Grants
  • 资助金额:
    $39.42万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Daniel Chambers
  • 依托单位:
Centre for Research Excellence in Pulmonary Fibrosis
  • 批准号:
    nhmrc : 1116371
  • 项目类别:
    Centres of Research Excellence
  • 资助金额:
    $170.92万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Daniel Chambers
  • 依托单位:
Conquering the final frontier in lung transplantation - Mesenchymal stromal cell therapy for chronic lung allograft dysfunction
  • 批准号:
    nhmrc : 1103789
  • 项目类别:
    Project Grants
  • 资助金额:
    $130.38万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Daniel Chambers
  • 依托单位:
海外基金